+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

ResApp Health Ltd (RAP) - Product Pipeline Analysis, 2020 Update

  • ID: 5240121
  • Company Profile
  • January 2021
  • 39 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Alere Inc
  • GE Healthcare
  • Genetic Signatures Ltd
  • ResMed Inc
  • Welch Allyn Inc
  • MORE
ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseases. The company’s products include SleepCheck, an at-home sleep apnoea screening app for customers to self-assess their risk of sleep apnoea; and ResAppDx-EU, a smartphone based acute respiratory disease diagnostic test for respiratory disease in adults and children. ResApp has license from The University of Queensland for technology that uses sound to diagnose respiratory diseases including upper respiratory tract infections, bronchitis, pneumonia, asthma and chronic obstructive pulmonary disease (COPD). Markets for ResApp’s technology include emergency department and regular clinic use by healthcare providers, at-home use by consumers and telehealth use through partnerships with telehealth service providers. ResApp is headquartered in Brisbane, Queensland, Australia.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company ResApp Health Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Alere Inc
  • GE Healthcare
  • Genetic Signatures Ltd
  • ResMed Inc
  • Welch Allyn Inc
  • MORE
ResApp Health Ltd Company Overview
  • ResApp Health Ltd Company Snapshot
  • ResApp Health Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • ResApp Health Ltd - Pipeline Analysis Overview
  • Business Description
  • ResApp Health Ltd - Key Facts
  • ResApp Health Ltd - Major Products and Services
  • ResApp Health Ltd Pipeline Products by Development Stage
  • ResApp Health Ltd Ongoing Clinical Trials by Trial Status
ResApp Health Ltd Pipeline Products Overview
  • Handheld Breathing Monitor
  • Handheld Breathing Monitor Product Overview
  • ResApp Mobile App - Warfighter
  • ResApp Mobile App - Warfighter Product Overview
  • ResAppDx Integrated Medetective App
  • ResAppDx Integrated Medetective App Product Overview
  • ResAppDx Mobile App - Adult Use
  • ResAppDx Mobile App - Adult Use Product Overview
  • ResAppDx Mobile App - Adult Use Clinical Trial
  • ResAppDx Mobile App - Pediatric Use
  • ResAppDx Mobile App - Pediatric Use Product Overview
  • ResAppDx Mobile App - Pediatric Use Clinical Trial
  • Respiratory App
  • Respiratory App Product Overview
  • SleepCheck
  • SleepCheck Product Overview
  • SleepCheck Clinical Trial
  • Wearable Breathing Monitor
  • Wearable Breathing Monitor Product Overview
ResApp Health Ltd - Key Competitors

ResApp Health Ltd - Key Employees
  • ResApp Health Ltd - Key Employee Biographies
ResApp Health Ltd - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • ResApp Health Ltd, Recent Developments
  • Jun 18, 2020: ResApp signs MOU to develop respiratory app for consumers
  • Feb 18, 2020: ResApp completes functional testing of handheld and wearable device prototypes
  • Dec 19, 2019: ResApp to undertake a clinical study of COPD screening in Indigenous Australians
  • Dec 12, 2019: ResApp receives $1.8 million R&D tax incentive cash rebate
  • Oct 02, 2019: ResApp receives Australian TGA Approval for Smartphonebased Diagnostic Test for Paediatric Respiratory Disease
  • Sep 30, 2019: ResApp receives positive results from prospective at-home sleep apnoea study
  • Aug 23, 2019: ResApp receives CE mark for the world’s first smartphone- based diagnostic test for respiratory disease
  • Jul 29, 2019: ResApp Health: Update for the quarter ending 30 June 2019
  • Jul 01, 2019: At-home obstructive sleep Apnoea study update
  • Jun 19, 2019: ResApp Health: Extension of CEO and Managing Director’s Contract
Appendix
  • Methodology
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • ResApp Health Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • ResApp Health Ltd Pipeline Products by Equipment Type
  • ResApp Health Ltd Pipeline Products by Indication
  • ResApp Health Ltd Ongoing Clinical Trials by Trial Status
  • ResApp Health Ltd, Key Facts
  • ResApp Health Ltd, Major Products and Services
  • ResApp Health Ltd Number of Pipeline Products by Development Stage
  • ResApp Health Ltd Pipeline Products Summary by Development Stage
  • ResApp Health Ltd Ongoing Clinical Trials by Trial Status
  • ResApp Health Ltd Ongoing Clinical Trials Summary
  • Handheld Breathing Monitor - Product Status
  • Handheld Breathing Monitor - Product Description
  • ResApp Mobile App - Warfighter - Product Status
  • ResApp Mobile App - Warfighter - Product Description
  • ResAppDx Integrated Medetective App - Product Status
  • ResAppDx Integrated Medetective App - Product Description
  • ResAppDx Mobile App - Adult Use - Product Status
  • ResAppDx Mobile App - Adult Use - Product Description
  • ResAppDx Mobile App - Adult Use - A Pilot, Double-blind Study of ResApp Smartphone Application for Screening the Chronic Obstructive Pulmonary Disease in an Indigenous Australian Population
  • ResAppDx Mobile App - Adult Use - ResApp Clinical Study for Diagnosis of Respiratory Conditions
  • ResAppDx Mobile App - Adult Use - The Breathe Easy Study: Developing Digital Diagnostic Tests for Respiratory Diseases Using Non-contact Sound Recordings in Children and Adults. Initial Technical Training and Development Phase and Secondary Blinded Prospective Diagnostic Accuracy Studies
  • ResAppDx Mobile App - Pediatric Use - Product Status
  • ResAppDx Mobile App - Pediatric Use - Product Description
  • ResAppDx Mobile App - Pediatric Use - The Breathe Easy Study: Developing Digital Diagnostic Tests for Respiratory Diseases Using Non-contact Sound Recordings in Children and Adults. Initial Technical Training and Development Phase and Secondary Blinded Prospective Diagnostic Accuracy Studies
  • Respiratory App - Product Status
  • Respiratory App - Product Description
  • SleepCheck - Product Status
  • SleepCheck - Product Description
  • SleepCheck - Double-blind Prospective Study to Assess the Efficacy of ResAppDx in Subjects with Obstructive Sleep Apnoea (OSA)
  • Wearable Breathing Monitor - Product Status
  • Wearable Breathing Monitor - Product Description
  • ResApp Health Ltd, Key Employees
  • ResApp Health Ltd, Key Employee Biographies
  • ResApp Health Ltd, Subsidiaries
  • Glossary
List of Figures
  • ResApp Health Ltd Pipeline Products by Equipment Type
  • ResApp Health Ltd Pipeline Products by Development Stage
  • ResApp Health Ltd Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 3
  • Alere Inc
  • Welch Allyn Inc
  • Genetic Signatures Ltd
  • ResMed Inc
  • GE Healthcare
Note: Product cover images may vary from those shown
Adroll
adroll